Tradestie Institutional Equity Comparison Engine

CAMP vs SLS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SLS Overall Edge

SLS Captures Institutional Edge (3โ€“0 Pillars ยท 4โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SELLAS Life Sciences Group, Inc. Common Stock (SLS) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CAMP trades at N/M Forward P/E with -991.8% operating margin (+138.9% YoY revenue) versus SLS at N/M Forward P/E and 0.0% operating margin (-82.5% YoY). In options structure, CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SLS sits in BREAKOUT (74th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CAMP N/M vs SLS N/M Fwd P/E
Growth & Margin Winner SLS
Op Margin -991.8% vs 0.0% ยท YoY +138.9% vs -82.5%
Momentum & Technical Winner SLS
1Y -2.4% vs +1239.2% ยท 52W Pos 23% vs 76%
Options & Structure Winner SLS
UNCLASSIFIED (N/A IV) vs BREAKOUT (74th %ile IV)
CAMP NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$4.00
+3.63% 1D
Market Cap $238.5M
1M Return +27.39%
1Y Return -2.44%
Forward P/E N/M
Unified AI Score
43.9 / 100 HOLD
Tech 34.0 Fund 40.0 Flow 50.0 Mom 40.0
SLS NASDAQ
SELLAS Life Sciences Group, Inc. Common Stock
Pharmaceutical Preparations
$19.15
+156.36% 1D
Market Cap $1.6B
1M Return +82.55%
1Y Return +1239.16%
Forward P/E N/M
Unified AI Score
34.1 / 100 SELL
Tech 5.0 Fund 37.0 Flow 66.0 Mom 38.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CAMP -2.44% SLS +1239.16% Spread: +1241.6 pp (SLS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CAMP Revenue SLS Revenue CAMP Op. Margin SLS Op. Margin Margin Edge
FY2013 N/A $0M N/A -1145.5% SLS
FY2014 N/A $10M N/A -471.1% SLS
FY2020 N/A $0M N/A -893.8% SLS
FY2021 N/A $10M N/A -332.8% SLS
FY2022 N/A $0M N/A -4195.0% SLS
FY2023 $0M N/A -14822.6% N/A CAMP
FY2024 $0M N/A -8142.3% N/A CAMP
FY2025 $0M N/A -1502.4% N/A CAMP

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CAMP (3) vs SLS (4)
Institutional Metric CAMP SLS Criterion Row Winner
Market Capitalization Scale $238.5M $1.6B Larger Scale SLS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +138.9% -82.5% Higher Growth CAMP
Operating Margin (TTM) Profitability -991.8% 0.0% Higher Margin SLS
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -146.1% -40.3% Higher ROE SLS
52-Week Range Position Momentum 23% ($3โ€“$8) 76% ($1โ€“$25) Stronger Trend SLS
Beta / 30D Volatility Risk Regime 1.35ฮฒ ยท 94% Vol 1.38ฮฒ ยท 568% Vol Lower Realized Risk CAMP
Unified Institutional Score Composite Signal 43.9 / 100 (HOLD) 34.1 / 100 (SELL) Higher Composite CAMP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CAMP vs SLS Buy Guide
CAMP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CAMP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SLS BREAKOUT
99d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 74th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live SLS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CAMP nor SLS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.